Quốc gia: Pháp
Ngôn ngữ: Tiếng Anh
Nguồn: HMA (Heads of Medicines Agencies)
avian infectious bronchitis virus lyophylisated 105 EID50
Pfizer
QI01AD07
Avian infectious bronchitis virus
Chicken
2013-03-20
1 _[Version 8, 10/2012] _ ANNEX I SUMMARY OF PRODUCT CHARACTERISTICS 2 1. NAME OF THE VETERINARY MEDICINAL PRODUCT Poulvac IB QX lyophilisate for suspension for spray for chickens 2. QUALITATIVE AND QUANTITATIVE COMPOSITION One dose contains: ACTIVE SUBSTANCE: Live attenuated Avian Infectious Bronchitis Virus, strain L1148 10 3.0 –10 5.0 EID 50 * . * EID 50 = 50% Embryo Infective Dose. EXCIPIENT: For a full list of excipients, see section 6.1. 3. PHARMACEUTICAL FORM Lyophilisate for suspension. 4. CLINICAL PARTICULARS 4.1 TARGET SPECIES Chickens. 4.2 INDICATIONS FOR USE, SPECIFYING THE TARGET SPECIES For active immunisation of chickens in order to reduce respiratory signs of Infectious Bronchitis caused by QX-like variants of Infectious Bronchitis virus. Onset of immunity: 3 weeks after vaccination. Duration of immunity: 63 days after vaccination. 4.3 CONTRAINDICATIONS Do not use during lay. Do not vaccinate future layers/breeders before 1 week of age. 4.4 SPECIAL WARNINGS The vaccine virus is capable of spreading to in contact birds for a minimum of 14 days after vaccination and appropriate care should be taken to separate vaccinated from non-vaccinated chickens. Precautionary measures should be taken to prevent spreading to wildlife. Cleaning and disinfection of the premises after vaccination is advisable. This vaccine should only be used after it has been established that the QX-like IBV variant strain is epidemiologically relevant. It is important to avoid introduction of the IB QX vaccine virus in Đọc toàn bộ tài liệu